Conmed Corporation

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$4.8Mgeneral payments (2019-2025)
$984Kresearch payments (2019-2025)
9,536clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $916K
2020 $440K
2021 $681K
2022 $732K
2023 $595K
2024 $683K
2025 $773K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Gastroenterology (Internal Medicine) $1.4M
Surgery $1.2M
Pulmonary Disease $281K
Pediatric Surgery $221K
Obstetrics & Gynecology $205K
Gynecologic Oncology $183K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Michael Harkins Tomball, TX Surgery $491,851.79
Naomi Nakao New York, NY $483,065.93
Ko Pen Wang Baltimore, MD Pulmonary Disease $278,842.81
Isaac Raijman Houston, TX Gastroenterology (Internal Medicine) $256,753.23
Todd Ponsky Cincinnati, OH Pediatric Surgery $206,472.49
Ricardo Estape Miami, FL Gynecologic Oncology $132,281.02
Sandeep Patel San Antonio, TX Gastroenterology (Internal Medicine) $102,921.91
Alyssa Choi Seattle, WA Gastroenterology (Internal Medicine) $100,139.21
Bahareh Nejad Roseville, CA Obstetrics & Gynecology $85,715.01
Alison Considine New Haven, CT Anesthesiology $80,732.98

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.